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using the Child-Pugh score and the MELD/Na score in January 2018.
The MELD/Na score is a scoring system for accessing the severity of chronic liver disease using values as serum bilirubin, serum creatinine, and the international normalized ratio for prothrombin time and sodium, to predict survival [ Table 1 ].
The Child-Pugh score is used to access the prognosis of chronic liver disease, mainly cirrhosis. The score employs five clinical measures of liver disease: total bilirubin, serum albumin, prothrombin time, ascites, and hepatic encephalopathy [ Table 2 ]. [6, 7] 
Results and dIscussIon
During this period, 6493 patients were hospitalized and 47 with liver cirrhosis were included in this study [ Table 3 ].
The median age was 64.3 years; 95.7% were male. The median hospitalization time was 10.7 days. The overall mortality rate was 68.1%.
Patients were classified according to the Child-Pugh score in Class A (17%), Class B (48.9%), and Class C (34%). The corresponding survival rate was as follows: class A (87.5%), Class B (30.4%), and Class C (31.25%).
The 1-year mortality rate was as follows: class A (12.5%), Class B (65.2%), and Class C (68.75%). The mortality rate after the 1 st year was as follows: class A (0%), Class B (4.3%), and Class C (0%). Palliative care needs were identified in Classes B and C [ Table 4 ].
The MELD/Na score intervals were >9 (2.15%), score 10-19 (46.8%), score 20-29 (27.7%), score 30-40 (19.1%), and score >40 (4.3%). Nearly 51.1% had a MELD/Na score >20 and 48.9% <20 [ Table 5 ].
In January 2018, 31.9% were alive. About 44.7% had died in <3 months, 10.6% between 3 and 6 months, and 4.3% after 6 months.
The study revealed that 59.6% of patients died before 12 months. They were end-of-life patients who needed palliative care to reduce the impact of the disease.
According to the Child-Pugh score, in <1 year, the mortality rate of patients in Class B was 65.2% and 68.7% in Class C, and according to the MELD/Na score, patients with a score >20 had 51.1% mortality.
Given these percentages, both classes of patients had criteria to be identified as end-of-life patients requiring special care.
Patients had a decrease in quality of life, clinical, psychological, social, and family changes. Therefore, therapeutic adjustment was necessary to control the worsening of the following symptoms: edema, ascites, fever, fatigue, tiredness, drowsiness, confusion, loss of appetite, pain, dyspnea, and increased bleeding.
conclusIons
According to the MELD/Na score, in a 3-month period after hospitalization, a number between 19.6% and 71.3% of patients had a mortality likelihood of 51.1%. These numbers of patients were in need of palliative care. The confirmed mortality rate was 44.7%, during these first 3 months.
According to the Child-Pugh score, our Classes B and C patients have a mortality of 65.2% and 68.75% at 1 year, respectively, needing palliative care.
The Child-Pugh score and the MELD/Na score represent a viable and easy-to-use tool to identify patients in need of palliative care, among those with liver cirrhosis.
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